机译:LKB1调节乳腺癌中的PRMT5活性
Ctr Rech Cancerol Lyon INSERM U1052 Lyon France;
Cairo Univ Clin Oncol Dept Fac Med Cairo Egypt;
Ctr Rech Cancerol Lyon INSERM U1052 Lyon France;
Ctr Rech Cancerol Lyon INSERM U1052 Lyon France;
Univ Southern Calif Norris Comprehens Canc Ctr Dept Biochem &
Mol Med Los Angeles CA USA;
Ctr Leon Berard Dept Oncol Lyon France;
Ctr Rech Cancerol Lyon INSERM U1052 Lyon France;
Lebanese Univ EDST Mol Tumor Genesis &
Anticanc Pharmacol Hadath Lebanon;
Lebanese Univ Canc Biol Stem Cells &
Mol Immunol Hadath Lebanon;
Ctr Leon Berard Dept Pathol Lyon France;
Ctr Rech Cancerol Lyon INSERM U1052 Lyon France;
arginine methylation; PRMT5; LKB1; threonine phosphorylation; breast cancer;
机译:LKB1调节乳腺癌中的PRMT5活性
机译:PRMT5 / WDR77复合物调节乳腺癌中ZNF326的替代剪接
机译:PRMT5 / WDR77复合物通过ZNF326调控乳腺癌的选择性剪接
机译:Stilbene类似物通过P-糖蛋白外排作为乳腺癌干细胞的抑制剂; 3D定量结构-活性关系研究(Stilbenes类似物对乳腺癌干细胞的抑制活性)
机译:自分泌和旁碱基信号调节炎症乳腺癌中的乳腺癌干细胞和上皮 - 间充质转换
机译:PRMT5通过调节LXRα/NF-κBp65途径促进有氧糖酵解和乳腺癌细胞的侵袭
机译:P> PRMT5通过调节LXRα/ NF-κBP65途径来促进有氧糖酵解和患乳腺癌细胞的侵袭 p>